Abstract: The present invention provides a novel gene-therapeutic agent for neurodegenerative diseases. The present invention allows Aß variants to be secreted out of cells and continuously supplies tau inhibitor peptides in the cells to allow wt Aß polymerization and wt tau polymerization to be slowed or inhibited and cytotoxicity to be reduced in the human body, and thus exhibits excellent effects of preventing, alleviating, and treating neurodegenerative diseases.
| # | Name | Date |
|---|---|---|
| 1 | 202337055958-TRANSLATIOIN OF PRIOIRTY DOCUMENTS ETC. [21-08-2023(online)].pdf | 2023-08-21 |
| 2 | 202337055958-STATEMENT OF UNDERTAKING (FORM 3) [21-08-2023(online)].pdf | 2023-08-21 |
| 3 | 202337055958-Sequence Listing in txt [21-08-2023(online)].txt | 2023-08-21 |
| 4 | 202337055958-Sequence Listing in PDF [21-08-2023(online)].pdf | 2023-08-21 |
| 5 | 202337055958-PROOF OF RIGHT [21-08-2023(online)].pdf | 2023-08-21 |
| 6 | 202337055958-PRIORITY DOCUMENTS [21-08-2023(online)].pdf | 2023-08-21 |
| 7 | 202337055958-POWER OF AUTHORITY [21-08-2023(online)].pdf | 2023-08-21 |
| 8 | 202337055958-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [21-08-2023(online)].pdf | 2023-08-21 |
| 9 | 202337055958-FORM 1 [21-08-2023(online)].pdf | 2023-08-21 |
| 10 | 202337055958-DRAWINGS [21-08-2023(online)].pdf | 2023-08-21 |
| 11 | 202337055958-DECLARATION OF INVENTORSHIP (FORM 5) [21-08-2023(online)].pdf | 2023-08-21 |
| 12 | 202337055958-COMPLETE SPECIFICATION [21-08-2023(online)].pdf | 2023-08-21 |
| 13 | 202337055958-MARKED COPIES OF AMENDEMENTS [05-02-2024(online)].pdf | 2024-02-05 |
| 14 | 202337055958-FORM 13 [05-02-2024(online)].pdf | 2024-02-05 |
| 15 | 202337055958-AMMENDED DOCUMENTS [05-02-2024(online)].pdf | 2024-02-05 |
| 16 | 202337055958-FORM 3 [20-02-2024(online)].pdf | 2024-02-20 |
| 17 | 202337055958-FORM 18 [24-01-2025(online)].pdf | 2025-01-24 |